Compounds > temoporfin
Page last updated: 2024-08-24

temoporfin and Carcinoma in Situ

temoporfin has been researched along with Carcinoma in Situ in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bing Tan, I; Copper, MP; Karakullukcu, B; Klop, WM; van Oudenaarde, K; van Veen, R; Wildeman, M1
Akram, S; Hamdoon, Z; Hopper, C; Jerjes, W; Mosse, CA; Upile, T1
Aans, JB; den Hollander, JC; Robinson, DJ; Sterenborg, HJ; van der Ende, ME; van der Snoek, EM1
Campbell, SM; Clifford, T; Curnow, A; Gould, DJ; Salter, L1
Campbell, SM; Curnow, A1
Andrejevic-Blant, S; Ballini, JP; Fontolliet, C; Hadjur, C; Monnier, P; van den Bergh, H; Wagnières, G1
Grosjean, P; Monnier, P; Radu, A; Zellweger, M1

Trials

1 trial(s) available for temoporfin and Carcinoma in Situ

ArticleYear
Photodynamic therapy outcome for oral dysplasia.
    Lasers in surgery and medicine, 2011, Volume: 43, Issue:3

    Topics: Aged; Aminolevulinic Acid; Carcinoma in Situ; Drug Administration Schedule; Female; Humans; Lasers, Semiconductor; Leukoplakia, Oral; Low-Level Light Therapy; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome

2011

Other Studies

6 other study(ies) available for temoporfin and Carcinoma in Situ

ArticleYear
Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2011, Volume: 268, Issue:2

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Disease-Free Survival; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Survival Rate

2011
Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3.
    Lasers in surgery and medicine, 2012, Volume: 44, Issue:8

    Topics: Adult; Anus Neoplasms; Carcinoma in Situ; HIV Infections; Humans; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Prospective Studies

2012
Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.
    The British journal of dermatology, 2004, Volume: 151, Issue:5

    Topics: Adult; Carcinoma in Situ; Female; Follow-Up Studies; Humans; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Treatment Outcome; Vulvar Neoplasms

2004
Extensive vulval intraepithelial neoplasia treated with a new regime of systemic photodynamic therapy using meta-tetrahydroxychlorin (Foscan).
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:4

    Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Mesoporphyrins; Middle Aged; Photochemotherapy; Vulvar Neoplasms

2008
Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
    British journal of cancer, 1997, Volume: 76, Issue:8

    Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cheek; Cricetinae; Drug Administration Schedule; Light; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Mouth Neoplasms; Photochemotherapy; Radiation-Sensitizing Agents; Tissue Distribution

1997
Pulse oximeter as a cause of skin burn during photodynamic therapy.
    Endoscopy, 1999, Volume: 31, Issue:9

    Topics: Burns; Carcinoma in Situ; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Finger Injuries; Humans; Mesoporphyrins; Middle Aged; Nails; Oximetry; Photochemotherapy; Photosensitizing Agents

1999